GGrantIndex
Sort

53,477 grants matching addiction

Neural circuitry and functional significance of extra-SCN pacemakers

$384,225
Shin Yamazaki · Ut Southwestern Medical Center · R01 · FY2020 · NS

RELIEPH for Interstitial Cystitis

$384,172
Yan Xu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK

Validation of Alcohol Exposure Biomarkers via Affinity Mass Spectrometry

$384,166
Urban A Kiernan · Intrinsic Bioprobes, Inc. · R44 · FY2009 · AA

Psychostimulant-Induced Plasticity of Nucleus Accumbens Interneurons

$384,142
Anne Elizabeth West · Duke University · R01 · FY2019 · DA

Integrating Addiction Research in Health Systems: The Addiction Research Network

$384,120
Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2019 · DA

Training in Research on Addictions in Interdisciplinary NeuroAIDS (TRAIN)

$384,097
Robert Kernachan Heaton · University Of California, San Diego · T32 · FY2021 · DA

Molecular and Behavioral Effects of Nicotine Deprivation

$384,049
Julie A Blendy · University Of Pennsylvania · P50 · FY2010 · CA

Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis

$384,018
Tomoo Iwakuma · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2021 · CA

Determining the neural substrates of model-based and model-free reinforcement-learning during Pavlovian conditioning

$384,018
John P O'Doherty · California Institute Of Technology · R01 · FY2020 · DA

Attentional control by uncertainty and reward: parietal and frontal mechanisms

$384,000
Jacqueline Gottlieb · Columbia University Health Sciences · R01 · FY2013 · MH

Medium Spiny Neuron Excitability and Motivation

$384,000
Christoph Kellendonk · Columbia University Health Sciences · R01 · FY2013 · MH

PHARMACOLOGICAL MODULATION OF COCAINE EFFECTS

$383,994
Johns Hopkins University · R01 · FY2002 · DA

PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT

$383,958
Karen Steinmetz · University Of California, San Francisco · N01 · FY2011 · DA

Drugs of Abuse & Synaptic Processes In Dopamine Systems

$383,926
Robert C Malenka · Stanford University · R01 · FY2006 · DA

Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement

$383,910
John F Neumaier · Seattle Inst For Biomedical/Clinical Res · R01 · FY2023 · DA

Optopharmacology and Sensors for Dissecting Opioid Action In Vivo

$383,894
Michael R Bruchas · University Of Washington · R61 · FY2021 · DA

Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit

$383,865
Alex Toker · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA

UCLA Training Program in the Translational Neuroscience of Drug Abuse (TNDA)

$383,860
Edythe D London · University Of California Los Angeles · T32 · FY2020 · DA

Frontiers in Addiction Research and Pregnancy

$383,851
Gerald Schatten · Magee-Women'S Res Inst And Foundation · R25 · FY2018 · DA

Interaction of Emotional Perception and Visual Attention

$383,798
Luiz Pessoa · Univ Of Maryland, College Park · R01 · FY2019 · MH

Plasticity in Unitary Synaptic Connections

$383,794
Vernon Daniel Madison · Stanford University · R01 · FY2012 · MH

Adherence to HIV Therapy in Heroin Addicts: Oral vs Extended Release Naltrexone

$383,790
George E Woody · University Of Pennsylvania · R01 · FY2010 · DA

Dynorphin, a novel paracrine factor that regulates insulin secretion

$383,750
Manuel Blandino-Rosano · University Of Miami School Of Medicine · R01 · FY2023 · DK

Cell Subtype Transcriptional Mechanisms in Cocaine Addiction

$383,750
Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2019 · DA

An ACE Inhibitor as a Treatment for Methamphetamine Dependence

$383,750
Thomas Frederick Newton · Baylor College Of Medicine · R01 · FY2008 · DA